Here are the morning's top stories on Tuesday, November 19, 2024… If you’re one of the unlucky people who get bitten by a ...

Issued on behalf of Avant Technologies Inc.USA News Group News Commentary VANCOUVER, BC, Nov. 20, 2024 /PRNewswire/ -- Healthcare is undergoing a transformative shift, with new technologies ...

Transforming Healthcare lecture series highlights efforts to expand therapy from cancer to autoimmune diseases While ...

As we age, our muscles atrophy. Earlier this year, researchers found that hepatocyte growth factor (HGF), a protein critical in skeletal muscle development loses its functionality due to nitration as ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

Candidate VY1706 demonstrates significant reductions of tau at low doses in NHP study; IND and CTA filings anticipated in ...

HAMPTON, N.J., Nov. 20, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:CLDX) today announced that the first patient has been dosed in the Company’s Phase 1a study of CDX-622 in healthy volunteers. CDX-622 is a ...

A drug in advanced development for myasthenia gravis also showed promise as a treatment for primary Sjögren's syndrome, a ...

There are fears of a rise in TBEV, West Nile and Usutu after birds and insects carrying viruses were found in England ...

In this study, our results uncover the function and mechanism of CHMP5 in the regulation of cell senescence and bone formation in osteogenic cells. Deletion of Chmp5 causes endolysosomal dysfunction ...

This important study identifies the "H-state" as a potential conformational marker distinguishing amyloidogenic from non-amyloidogenic light chains, addressing a critical problem in protein misfolding ...

"Integrating our SurgiCount+ and Triton technologies on one platform will set a new industry standard for quantifying blood loss and continuing to ... and long DNA synthesis, to support antibody ...